Medical Cannabis Use With a Co-Occurring Cannabis Use Disorder
A veteran’s cannabis genuinely controls pain nothing else has. It has also, over the past year, become something his daughter no longer recognizes — and something he now meets structured criteria for a disorder around.
F.A.'s daughter moved back in two years ago, partly, she's told him, to keep an eye on things — and lately what worries her isn't his pain, which the cannabis genuinely helps, but how much of it he's using. He is fifty-one, a veteran whose chronic neuropathic pain from a service-related injury ended his long-haul driving career years ago; on good days he restores model trains in the garage, a hobby he's only recently picked back up and says is one of the few things that still feels like himself.
He was prescribed medical cannabis three years ago for his neuropathic pain, under a state program, after opioids caused constipation and sedation he found intolerable, and he credits it with real, meaningful pain relief he hasn't found elsewhere. Over the past year, his daughter has grown increasingly worried — not about the pain relief, but about how his use has changed. He now uses well beyond what his medical program recommends, has twice run out of his allotment early and purchased more through unregulated sources, and has described feeling unable to function without it even on days his pain is comparatively mild. He meets criteria for cannabis use disorder on structured screening today — tolerance, use in larger amounts than intended, and continued use despite his daughter's repeated expressed concern — layered directly on top of a legitimate, ongoing medical indication that hasn't gone away and isn't going to.
His daughter sat in on today's visit at his own request. He said he wanted that specifically so nothing got lost between what he tells the clinic and what he tells her at home, the two accounts finally matching.
A real medical benefit and a real disorder, in the same patient
I don't think the right frame here is "continue or stop." He has a genuine, well-documented pain indication that hasn't resolved and hasn't responded better to anything else we've tried, and he also meets structured criteria for cannabis use disorder. Dawson and colleagues' 2024 systematic review and meta-analysis in Drug and Alcohol Dependence found a pooled cannabis use disorder prevalence of roughly 25% among people using medicinal cannabis — somewhat higher than the rate among recreational users — so this overlap isn't rare or a sign we've somehow mismanaged his case. Both facts are real. The task is stabilizing his use inside a structured, monitored medical framework while addressing the disorder directly, not choosing one fact to act on and ignoring the other.
I agree with that framing, and I want to flag something concrete and immediate within it: he's twice purchased from unregulated sources when his allotment ran out. That's a discrete safety issue — unregulated product carries real, unknown potency and contamination risk — separate from the broader disorder question, and I'd want to address it specifically and urgently, not fold it generally into "use disorder treatment" as one item among several.
That's fair, and I'd add that a program adjustment allowing a higher, still monitored allotment might reduce his need to seek unregulated product at all, which addresses your concern directly rather than only through counseling — especially since, per the prevalence data I just cited, this overlap is common enough that our program should probably have a standing answer for it rather than improvising one each time.
I'd add one more distinction worth naming directly with him: whether he still medically needs cannabis, and whether his relationship with it has become disordered, are genuinely separate questions, even though they're tangled together in his case right now. A German cross-sectional study of chronic pain patients on medical cannabis found that a strict DSM-5 reading flagged nearly 30% with a use disorder, but that figure dropped to roughly 2% once criteria plausibly explained by the pain-relief motive itself — not addiction — were set aside; the point isn't that his screening result is wrong, since he also has genuinely disorder-specific findings his daughter has raised, but that the screen alone can't settle this and a direct conversation with him has to. I want to ask him directly about using it "even on mild pain days" — that's not really a pain-management question, and exploring it honestly with him, rather than assuming the answer, is part of taking the disorder seriously without dismissing the real medical history behind it.
Agreed: F.A. continues medical cannabis through his monitored program, with allotment reassessed and cannabis use disorder counseling started in parallel, including a direct conversation about his use on lower-pain days.
Not agreed: how a monitored medical cannabis program should formally handle a patient who meets use disorder criteria — whether continuation should require a documented behavioral treatment component going forward as standard practice, or remain a case-by-case clinical judgment. The pain medicine specialist prefers a formal, standing program requirement; the addiction medicine specialist worried a formal requirement could function as a barrier discouraging patients from disclosing exactly the kind of honest concern F.A.'s daughter raised.